A Phase I/II Study of Olaparib with Entinostat in the Treatment of Recurrent, Platinum-Refractory or Resistant, Homologous Recombination Repair Proficient Ovarian, Primary Peritoneal and Fallopian Tube Cancers

Brief Summary

Type:
Ovarian

Study Type:
Treatment

Phase:
I/II

ClinicalTrials.gov Identifier:
NCT03924245

Study #:
STUDY00145349

Start Date:
Mar 30, 2020

Full Details and Eligibility at clinicaltrials.gov

By taking part in a clinical trial, you have access to potentially effective treatments not available elsewhere. Additionally, you will contribute to cancer research, which can help other cancer patients in the future. Read the full details of this specific clinical trial by clicking on the link below.

ClinicalTrials.gov ID: NCT03924245

View Complete Trial Details & Eligibility at ClinicalTrials.gov